AKT1 and nonpapillary renal cell carcinoma: Based on our experimental results, we hypothesize that in ccRCC, IFI16 may directly bind to the promoter region of IL6, thereby enhancing its transcription and translation, and activating the PI3K/AKT signaling pathway.